Navigation Links
Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair
Date:5/14/2009

COPPERTONE Continues Legacy of Innovation with New Research on Antioxidant-Enhanced Suncare

KENILWORTH, N.J., May 14 /PRNewswire-FirstCall/ -- In time for warmer weather, Schering-Plough (NYSE: SGP), introduces COPPERTONE(R), NutraShield(R) with Dual Defense(R), a new line of sunscreens enriched with antioxidants to help promote natural skin repair by neutralizing harmful free radicals created by UV exposure.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090514/NY16746 )

Topical antioxidants can offer cosmetic skin-enhancing benefits when added to a broad spectrum sunscreen. During the course of research, scientists at the COPPERTONE(R) Solar Research Center discovered that not all topical antioxidants are created equal. In addition, the results of independent studies presented by the makers of COPPERTONE at a recent American Academy of Dermatology meeting show that exposure to sunlight can cause some antioxidants to become skin-damaging pro-oxidants. COPPERTONE NutraShield contains specially-selected antioxidants that continue to function even in the presence of UV light. Based upon the results of an ex vivo study, the formula is proven to reduce free radical formation by 74 percent in skin exposed to UV light(1).

In a clinical study conducted by an independent laboratory, results revealed that with daily use on the face, COPPERTONE NutraShield helped reduce visible signs of skin aging and improved skin elasticity, texture and clarity in as little as two weeks in women who showed signs of mild to moderate photo damage (premature skin aging).(1) By the conclusion of the 12-week study, women using NutraShield also experienced, on average, a 20 percent reduction in the appearance of fine lines and wrinkles.(1)

"My patients want to help prevent sun damage and to keep their skin looking youthful," said Dr. Elizabeth Hale, Clinical Associate Professor of Dermatology at the New York University School of Medicine. "To help address these skincare needs, it's convenient to use a broad spectrum, high-SPF sunscreen with antioxidants. I recommend my patients make sun protection a year-round habit to prevent further damage."

A growing body of research reveals that daily sun exposure during everyday activities can contribute to skin damage that appears as fine lines and wrinkles as well as certain types of skin cancer. In response to these findings and consumer demand for multi-benefit skincare products, COPPERTONE developed its NutraShield line -- an SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body -- in lightweight formulas perfect for daily use to help protect and nourish skin.

"COPPERTONE has a legacy of continuous innovation to meet the changing needs of consumers," said Robert Bianchini, PhD, Vice President of R&D, Global Skincare at Schering-Plough Consumer HealthCare. "This year, we're offering consumers powerful broad spectrum sunscreens that also contain what we've discovered to be effective blends of antioxidants to help neutralize free radicals in skin."

(1) Data on file.

About COPPERTONE(R)

COPPERTONE(R), NutraShield(R) and Dual Defense(R) are registered trademarks of Schering-Plough HealthCare Products, Inc.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE:

The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R), NutraShield(R) with Dual Defense(R),. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded or generic competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A. "Risk Factors" in Schering-Plough's First Quarter 2009 10-Q, filed May 1, 2009.


'/>"/>
SOURCE Schering-Plough
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Introducing Ashley Koff Approved (AKA): the Stamp of Nutrition for Optimal Health
2. Introducing solixir(TM)... The First All-Natural Sparkling Botanical Beverage to Hydrate Body and Soul
3. For the First Time in U.S. History, Congress Addresses the Needs of the Congenital Heart Defect Population by Introducing the Congenital Heart Futures Act
4. National Patient Advocate Foundation Hails Senator Rockefeller, Representative Courtney for Introducing Preexisting Conditions Bill, Ensuring Patient Access to Health Coverage
5. National Patient Advocate Foundation Hails Senator Rockefeller, Representative Schwartz for Introducing Preexisting Conditions Bill, Ensuring Patient Access to Health Coverage
6. High-Tech Meets Luxury at New Dental Practice: Introducing Westchester Smile Design
7. Photos: Olay(R) Resignals the Future of Skin Care Introducing NEW Olay(R) Professional Pro-X
8. A Recession-Resistant Business? Introducing FertilityAuthority.com
9. Introducing a Kitchen for Your Mind: The Ojai Valley Inn & Spa Artists Cottage
10. American Dental Association Applauds Legislators for Introducing Meth Mouth Bill
11. Introducing HEAL-WA--New Initiative Brings Evidence-Based Health Sciences Information to Health Professionals in Washington State
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: